David Einhorn’s hedge fund Greenlight Capital picked up a brand new stake in Kenvue Inc. KVUE — previously the buyer healthcare division of Johnson & Johnson JNJ — within the fourth quarter, in response to a public submitting Wednesday.
Greenlight acquired a few $12 million stake in Kenvue within the fourth quarter, whereas additionally including an almost $2.7 million publicity to Israeli generic-drug large Teva Pharmaceutical Industries Ltd. TEVA, in response to a 13F quarterly submitting with the U.S. Securities and Alternate Fee.
The…
Grasp your cash.
Subscribe to MarketWatch.
Get this text and all of MarketWatch.
Entry from any system. Wherever. Anytime.
Subscribe Now
Already a subscriber?
Log In
